Number of the records: 1
skleróza multiplex
SYS d009103 LBL 00000cz--a2200000n--4500 005 20250606213328.4 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 065 $a C10.114.375.500 065 $a C10.314.350.500 065 $a C20.111.258.250.500 066 $a 01 $c 03 089 $a 616.832-004 150 $a skleróza multiplex $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a MS (Multiple Sclerosis) $2 eng 450 $w v $a Multiple Sclerosis, Acute Fulminating $2 eng 450 $w v $a Sclerosis, Disseminated $2 eng 450 $w v $a skleróza roztrúsená $2 slo 450 $w v $a sclerosis multiplex $2 slo 450 $w v $a MS $2 slo 450 $w v $a skleróza multiplex akútna fulminantná $2 slo 450 $w v $a skleróza diseminovaná $2 slo 550 $7 sllk_us_auth*d009188 $Y Myelitis, Transverse $w p $a myelitída transverzálna 550 $7 sllk_us_auth*d009188 $Y Myelitis, Transverse $w b $a myelitída transverzálna 550 $7 sllk_us_auth*d063308 $Y Myelin-Oligodendrocyte Glycoprotein $w b $a MOG (myelínový oligodendrocytový glykoproteín) 680 9-
$i An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) $2 eng 750 -2
$a Multiple Sclerosis $2 eng 980 $x M
Number of the records: 1